EASD 2025
15 - 19 September 2025
Comparative Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide on Cardiovascular Outcomes in US Medicare Beneficiaries With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Keywords
Get notified when materials for EASD 2025 and future congresses become available:
Get notified when materials for EASD 2025 and future congresses become available:
Success
We will notify you when new materials become available for EASD 2025 and future congresses.
We will keep you updated in your inbox:
Almost Done